Clinical Trial

MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors

Name: MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors — clinical trial record (NCT07004647)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study is a single-arm, dose-escalation, investigator-initiated exploratory clinical trial designed to evaluate the tolerability, safety, pharmacokinetic profile, and preliminary efficacy of MT027 Cell Injection in patients with advanced primary or secondary peritoneal tumors.

Trial Details

NCT Number	NCT07004647
Lead Sponsor	Ruijin Hospital
Conditions	Peritoneal Tumor
Enrollment	10 participants
Start Date	2025-03-15
Primary Completion	2028-10-30 (estimated)
Study Completion	2028-11-30 (estimated)
Updated on ClinicalTrials.gov	2025-06-04